{"entity":{"id":"macrophage-states","kind":"term","name":"Macrophage states beyond M1 and M2","aka":[],"tldr":"What a macrophage is doing depends on where it came from, where it sits, and the signals and history it has had, so the two-box labels M1 and M2 describe a laboratory comparison and not every macrophage in a tissue. In a tumour, a macrophage's label does not on its own show what it is doing to the cancer or to T cells.","summary":"A macrophage's lineage is its developmental origin; its state is a set of activity programmes at one time. A state label describes selected features and is not a complete biography. The M1 and M2 scheme grew from simplified experiments, with interferon gamma and microbial stimulation giving M1-like cells and interleukin-4 giving M2-like cells, and it is ambiguous unless the source, the stimulus and the markers are stated. A consensus framework asks authors to report the source of the macrophages, the activators used and a defined set of markers (Murray et al., 2014). When human macrophages were stimulated with diverse signals, 299 transcriptomes revealed a spectrum of activation states that extends the M1 and M2 model (Xue et al., 2014). In mice, tissue-resident macrophages had distinct enhancer landscapes beyond what developmental origin explained, and the local environment could reshape transplanted precursors and even reprogramme differentiated macrophages moved to a new environment (Lavin et al., 2014). Together these support diversity and plasticity without showing that any macrophage can be converted to any desired state.","asOf":"2026-11-10","links":[{"label":"Macrophage activation and polarization: nomenclature and experimental guidelines.","url":"https://doi.org/10.1016/j.immuni.2014.06.008"},{"label":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation.","url":"https://doi.org/10.1016/j.immuni.2014.01.006"},{"label":"Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment.","url":"https://doi.org/10.1016/j.cell.2014.11.018"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":["cd163"],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["macrophage","tumor-associated-macrophages","inflammation","myeloid-derived-suppressor-cells"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["In a tumour, a tumour-associated macrophage is named for its location, and its state and tested functions are separate questions. A tumour can hold several programmes in different neighbourhoods or at different times. An expression cluster can suggest a repair, interferon or lipid-handling programme, which is a hypothesis; it does not establish that the cells suppress T cells, kill cancer cells or would respond to a macrophage-directed drug. One marker such as CD163 does not establish a universal suppressive state, a change in proportions between two biopsies does not show that the same cells changed state, and the plain statement that M1 is good and M2 is bad loses the tissue and experiment that give a response its meaning.","Macrophages are described with protein panels, flow cytometry and single-cell RNA, and the report needs the identification rules, tissue or culture source, stimulation, collection time and denominator, because a fraction of recovered macrophages is not cells per area of tissue. A function such as engulfment or the effect on stimulated T-cell proliferation needs its own test with viability and comparator controls.","Consider a fictional culture comparison at 24 hours, scored with one method on a 0 to 1 scale of arbitrary RNA programme units. Profile A has interferon, lipid-handling and antigen-display scores of 0.80, 0.35 and 0.65; profile B has 0.45, 0.85 and 0.55. These six invented values are not measurements from Xue et al., fractions of cells or universal M1/M2 cutoffs. Several selected programmes coexist in each profile. The axes are summaries of expression, not independent switches that can be set or reversed at will. Even an antigen-display RNA score needs a separate functional presentation test. A real comparison also needs the macrophage identification rules, source, exposures, sampling time and scoring method. A change in profile proportions between samples would not establish that the same cells converted from one state to another."],"provenance":{"editedBy":"OnCo education audit","editedOn":"2026-11-10"},"category":"Immunology"},"route":"/terms/macrophage-states/","neighbours":{"target":[{"id":"cd163","kind":"target","name":"CD163","route":"/targets/cd163/"}],"term":[{"id":"immune-system","kind":"term","name":"Immune system","route":"/terms/immune-system/"},{"id":"inflammation","kind":"term","name":"Inflammation","route":"/terms/inflammation/"},{"id":"macrophage","kind":"term","name":"Macrophage","route":"/terms/macrophage/"},{"id":"myeloid-derived-suppressor-cells","kind":"term","name":"Myeloid-derived suppressor cells (MDSCs)","route":"/terms/myeloid-derived-suppressor-cells/"},{"id":"tumor-associated-macrophages","kind":"term","name":"Tumour-associated macrophages (TAMs)","route":"/terms/tumor-associated-macrophages/"}]}}